SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history.
Related news for (SNWV)
- Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
- Sanuwave Health Selected for Inclusion in Russell 2000® Index
- Sanuwave Health Appoints Greg Bazar to Board of Directors
- SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
- Sanuwave Health to Uplist to the Nasdaq Global Market